Graham holds a PhD in Neuropharmacology from the University of Edinburgh Medical School. His more than 30 years of industry experience includes clinical operations, project management, regulatory consulting and business development. Formerly VP, Clinical Development, Travecta Therapeutics, Graham has also held senior management roles in UK and Singapore with Parexel, ICON, Quintiles and Syneos. He has directly managed 20 Phase II/III clinical programs that successfully gained marketing approval through submission to the US FDA.
